Follow-up to Danielle Ternyila, Associate Editor to Targeted Oncology, Headquarted in NY. She wrote an article on Leronlimab on April 9th/2020. fully six months ago. Perhaps someone on the board with knowledge of the art..molecule might Tweet the young lady and perhaps she could do a follow-up on our current position. She knows the Moleculevery well and is seemingly impressed. I dig and
I don't tweet. Think of me, as a bird dog....maybe even a hound dog.